SCHEMBL3162806

SCHEMBL3162806

CC(=O)NCCNc1cc(NC(=O)CN2CCN(c3ccc(Cl)cc3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK3 P52333 1/20 0.51
▸ DEGS1 O15121 1/20 0.49
▸ MAPT P10636 6/20 0.48
▸ TSHR P16473 5/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ DRD2 P14416 1/20 0.48
▸ DRD4 P21917 1/20 0.48
▸ EGFR P00533 2/20 0.47
▸ ALDH1A1 P00352 3/20 0.46
▸ CYP1A2 P05177 2/20 0.46
▸ CYP3A4 P08684 2/20 0.46
▸ CYP2D6 P10635 2/20 0.46
▸ CYP2C9 P11712 2/20 0.46
▸ CYP2C19 P33261 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ LMNA P02545 2/20 0.46
▸ HTT P42858 2/20 0.46
▸ FPR2 P25090 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3162425 0.94 EGFR (0.53) JAK3MAPTTSHREGFRALDH1A1
SCHEMBL3164831 0.92 MAPT (0.50) JAK3MAPTTSHRNPSR1EGFR
SCHEMBL3166249 0.92 GAA (0.54) JAK3DEGS1MAPTTSHREGFR
SCHEMBL3170421 0.92 SMN1; SMN2 (0.55) JAK3TSHREGFRALDH1A1SMN1; SMN2
SCHEMBL3161698 0.91 ALDH1A1 (0.54) DEGS1DRD4EGFRALDH1A1SMN1; SMN2
SCHEMBL3175543 0.90 EGFR (0.50) JAK3MAPTTSHREGFRALDH1A1
SCHEMBL3162253 0.90 ALDH1A1 (0.52) MAPTNPSR1DRD4ALDH1A1SMN1; SMN2
SCHEMBL3165286 0.90 USP2 (0.57) MAPTTSHRDRD4ALDH1A1SMN1; SMN2
SCHEMBL3258722 0.89 EGFR (0.46) JAK3MAPTTSHREGFRALDH1A1
SCHEMBL3166342 0.88 ALDH1A1 (0.57) MAPTTSHREGFRALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback